⌘K

Login Start Free

Home/Filings/4/0001062993-24-020820

4//SEC Filing

Martini Jeffrey S 4

Accession 0001062993-24-020820

CIK 0001583648other

View on SEC.gov Company Profile

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 8:44 PM ET

Size

5.5 KB

Accession

0001062993-24-020820

Insider Transaction Report

Form 4

Period: 2024-12-13

PALVELLA THERAPEUTICS, INC.PVLA

Martini Jeffrey S

Chief Scientific Officer

Transactions

Award
Stock Option (right to buy)
2024-12-13+126,416→ 126,416 total
Exercise: $13.60Exp: 2034-12-13→ Common Stock (126,416 underlying)

Footnotes (1)

[F1]The stock options will vest in equal monthly tranches over 48 months.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

PALVELLA THERAPEUTICS, INC.

CIK 0001583648

Entity typeother

Related Parties

1

filerCIK 0001914560

Filing Metadata

Form type: 4
Filed: Dec 16, 7:00 PM ET
Accepted: Dec 17, 8:44 PM ET
Size: 5.5 KB

View on SEC.gov